Related Experiment Videos
Mononuclear cell factors that inhibit fibroblast collagen synthesis. I. In vitro conditions determining their
Abstract:
Peripheral blood mononuclear cells (PBMC) incubated either with phytohaemagglutinin-P (PHA) under serum-free conditions or with tuberculin purified protein derivative in the presence of 5% human blood group AB serum released into the culture medium factors that decreased collagen synthesis by dermal fibroblasts. These factors were first detected after incubation of PBMC with PHA for 24 h and were produced by non-adherent cells. The decrease in collagen synthesis was observed despite changes in conditions of fibroblast culture, the addition of a cross-linking inhibitor, and the use of different fibroblast cell lines.
Insights
Peripheral blood mononuclear cells (PBMC) release factors that inhibit collagen synthesis in dermal fibroblasts. These inhibitory factors are produced by non-adherent cells after stimulation with phytohaemagglutinin-P (PHA) or tuberculin purified protein derivative.
Area of Science:
- Immunology
- Cell Biology
- Dermatology
Background:
- Collagen synthesis is crucial for skin structure and wound healing.
- Peripheral blood mononuclear cells (PBMC) play a role in immune responses.
- Factors influencing fibroblast collagen production are not fully understood.
Purpose of the Study:
- To investigate the effect of stimulated PBMC on dermal fibroblast collagen synthesis.
- To identify the nature and source of factors released by PBMC that affect collagen production.
Main Methods:
- PBMC were stimulated with phytohaemagglutinin-P (PHA) or tuberculin purified protein derivative.
- Culture medium from stimulated PBMC was applied to dermal fibroblast cultures.
- Collagen synthesis in fibroblasts was measured under various conditions.
Main Results:
- Stimulated PBMC released factors into the culture medium that decreased collagen synthesis by dermal fibroblasts.
- These inhibitory factors were produced by non-adherent PBMC after 24 hours of PHA stimulation.
- The inhibitory effect was observed across different fibroblast cell lines and culture conditions.
Conclusions:
- Immune cells, specifically PBMC, can modulate extracellular matrix production in skin.
- Understanding these PBMC-derived factors may offer new therapeutic targets for skin conditions involving collagen remodeling.